Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 3 | 4 |
| List of Tables | 5 | 1 |
| List of Figures | 6 | 1 |
| Introduction | 7 | 1 |
| GBI Research Guidance | 7 | 1 |
| Overview: Orthobiologics | 8 | 2 |
| Applications of Orthobiologics | 8 | 2 |
| Global Orthobiologics : Market Characterization | 10 | 7 |
| Global Orthobiologics Market, Revenue ($m), 2002 2009 | 10 | 2 |
| Global Orthobiologics Market, Revenue Forecast ($m), 2009 2016 | 12 | 1 |
| Global Orthobiologics Market, Key Company Shares (%), 2009 | 13 | 2 |
| Global Orthobiologics Market, Dynamics | 15 | 1 |
| Market Drivers | 15 | 1 |
| Increasing Incidence of Arthritis and Other Orthopaedic Diseases Due to an Ageing Population and Obesity will Drive Future Growth of Orthobiologics | 15 | 1 |
| Technological Advances and Large Number of Products in the Pipeline is Expected to Drive the Growth of Orthobiologics | 15 | 1 |
| Increasing Number of Sports Injuries and Road Accidents to Drive Growth in Orthobiologics Market | 16 | 1 |
| Government Initiatives such as the Healthcare Reform Act and the Delay of Retirement to Drive the Orthobiologics Market | 16 | 1 |
| Market Restraints | 16 | 1 |
| Shortage of Surgeons Restricting the Number of Procedures | 16 | 1 |
| Global Orthobiologics Market: Category Analysis and Forecasts | 17 | 14 |
| Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 2009 | 17 | 1 |
| Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 2016 | 18 | 1 |
| Bone Graft Substitutes, Market Drivers | 19 | 1 |
| Increasing Demand for Synthetic Bone Graft Substitutes to Bolster Market Growth | 19 | 1 |
| Increasing Applications for Bone Graft Substitutes to Drive Growth | 19 | 1 |
| Increasing Incidence of Degenerative Disc Disease and Increasing Number of Fusion Procedures to Drive the Growth of Bone Graft Substitutes | 19 | 1 |
| Bone Graft Substitutes, Market Restraint | 19 | 1 |
| Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries and High Cost is slowing the Adoption | 19 | 1 |
| Global Viscosupplementation Market, Revenue ($m), Historic, 2002 2009 | 20 | 1 |
| Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 2016 | 21 | 1 |
| Viscosupplementation, Market Drivers | 22 | 1 |
| New Products with Lower Complication Rates and Lower Costs to Drive Demand | 22 | 1 |
| Limited Scope of Drugs to Treat End Stage Osteoarthritis to Drive Market for Viscosupplementation | 22 | 1 |
| Expansion of Applications to Other Osteoarthritis Affected Joints to Drive the Market | 22 | 1 |
| Viscosupplementation, Market Restraint | 22 | 1 |
| Pricing Challenges to Continue to Plague the Viscosupplementation Market | 22 | 1 |
| Global DBM Market, Revenue ($m), Historic, 2002 2009 | 23 | 1 |
| Global DBM Market, Revenue ($m), Forecast, 2009 2016 | 24 | 1 |
| DBM, Market Drivers | 25 | 1 |
| Advances in DBM Products over the Past Few Years have resulted in Increasing Adoption | 25 | 1 |
| The Success of DBM to Induce Bone Formation in Various Clinical Conditions will Increase Adoption | 25 | 1 |
| DBM, Market Restraint | 25 | 1 |
| Several Potential Disadvantages Such as the Potential to Transmit Human Immunodeficiency Virus May Act as a Restraint on Market Growth | 25 | 1 |
| Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 2009 | 26 | 1 |
| Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 2016 | 27 | 1 |
| Bone Growth Stimulators, Market Driver | 28 | 1 |
| Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth for Bone Growth Stimulators | 28 | 1 |
| Bone Growth Stimulators, Market Restraint | 28 | 1 |
| Lack of Exact Knowledge about the Mechanism of Action for These Devices and Lack of Studies in Specific Patient Groups will Restrict their Adoption | 28 | 1 |
| Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009 | 29 | 1 |
| Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016 | 30 | 1 |
| Global Orthobiologics Market: Country Analysis and Forecasts | 31 | 24 |
| Historic (2002 2009) and Forecast (2009-2016) Revenue, By Country | 31 | 1 |
| Orthobiologics Market, the US, Revenue ($m), 2002 2009 | 31 | 1 |
| Orthobiologics Market, the US, Revenue ($m), 2009 2016 | 32 | 1 |
| Orthobiologics Market, Canada, Revenue ($m), 2002 2009 | 33 | 1 |
| Orthobiologics Market, Canada, Revenue ($m), 2009 2016 | 34 | 1 |
| Orthobiologics Market, the UK, Revenue ($m), 2002 2009 | 35 | 1 |
| Orthobiologics Market, the UK, Revenue ($m), 2009 2016 | 36 | 1 |
| Orthobiologics Market, Germany, Revenue ($m), 2002 2009 | 37 | 1 |
| Orthobiologics Market, Germany, Revenue ($m), 2009 2016 | 38 | 1 |
| Orthobiologics Market, France, Revenue ($m), 2002 2009 | 39 | 1 |
| Orthobiologics Market, France, Revenue ($m), 2009 2016 | 40 | 1 |
| Orthobiologics Market, Italy, Revenue ($m), 2002 2009 | 41 | 1 |
| Orthobiologics Market, Italy, Revenue ($m), 2009 2016 | 42 | 1 |
| Orthobiologics Market, Spain, Revenue ($m), 2002 2009 | 43 | 1 |
| Orthobiologics Market, Spain, Revenue ($m), 2009 2016 | 44 | 1 |
| Orthobiologics Market, Brazil, Revenue ($m), 2002 2009 | 45 | 1 |
| Orthobiologics Market, Brazil, Revenue ($m), 2009 2016 | 46 | 1 |
| Orthobiologics Market, Japan, Revenue ($m), 2002 2009 | 47 | 1 |
| Orthobiologics Market, Japan, Revenue ($m), 2009 2016 | 48 | 1 |
| Orthobiologics Market, China, Revenue ($m), 2002 2009 | 49 | 1 |
| Orthobiologics Market, China, Revenue ($m), 2009 2016 | 50 | 1 |
| Orthobiologics Market, India, Revenue ($m), 2002 2009 | 51 | 1 |
| Orthobiologics Market, India, Revenue ($m), 2009 2016 | 52 | 1 |
| Orthobiologics Market, Australia, Revenue ($m), 2002 2009 | 53 | 1 |
| Orthobiologics Market, Australia, Revenue ($m), 2009 2016 | 54 | 1 |
| Global Orthobiologics Market: Competitive Assessment | 55 | 6 |
| Medtronic Inc. | 55 | 1 |
| Overview: | 55 | 1 |
| Pipeline Products | 55 | 1 |
| Genzyme Corporation | 56 | 1 |
| Overview | 56 | 1 |
| Marketed Products | 56 | 1 |
| Depuy, Inc.(Johnson &Johnson) | 56 | 1 |
| Overview | 56 | 1 |
| Marketed Products | 56 | 1 |
| Pipeline Products | 56 | 1 |
| Synthes, Inc. | 57 | 1 |
| Overview | 57 | 1 |
| Marketed Products | 57 | 1 |
| Smith &Nephew Plc | 58 | 1 |
| Overview | 58 | 1 |
| Marketed Products | 58 | 1 |
| Pipeline Products | 58 | 1 |
| Stryker | 59 | 1 |
| Overview | 59 | 1 |
| Marketed Products | 59 | 1 |
| Pipeline Products | 59 | 1 |
| Orthofix International N.V | 60 | 1 |
| Overview | 60 | 1 |
| Marketed Products | 60 | 1 |
| Pipeline Products | 60 | 1 |
| Global Orthobiologics Market: Product Pipeline Analysis | 61 | 12 |
| Orthobiologics Market: Pipeline Products Summary | 61 | 2 |
| Profiles of Promising Products Under Clinical Development: | 63 | 1 |
| Synthetic Bone Graft Substitutes | 63 | 1 |
| Augment Bone Graft (BioMimetic Therapeutics, Inc.) | 63 | 1 |
| Injectable Bone Graft/Scaffold (BioTech One Inc) | 64 | 1 |
| NanoFUSE Bone Graft (Nanotherapeutics, Inc.) | 64 | 1 |
| ST01 Bone Graft Substitute Material (Scil Technology Gmbh) | 64 | 1 |
| Structural Synthetic Bonegraft (Kensey Nash Corporation) | 64 | 1 |
| BMP | 65 | 1 |
| Amplify rhBMP-2 (Medtronic, Inc.) | 65 | 1 |
| BioChaperone BMP - Degenerative Disc Disease (Adocia) | 66 | 1 |
| BMP-7-Osteoarthritis (Stryker Corporation) | 66 | 1 |
| Infuse Bone Graft Posterolateral Fusions (Medtronic, Inc.) | 66 | 1 |
| Bone Growth Stimulators | 66 | 1 |
| Nanosurfaced Biomaterials - Closed Bone Augmentation (Nanovis Incorporated) | 66 | 1 |
| Hyaloss (Anika Therapeutics, Inc.) | 66 | 1 |
| Osteocel XC (Osiris Therapeutics, Inc.) | 67 | 1 |
| Osteoinductive Coating for Metallic Devices (Inion Oy) | 67 | 1 |
| Osteorate (Cardium Therapeutics, Inc.) | 67 | 1 |
| VeriCart | 67 | 1 |
| Bone Allograft | 68 | 1 |
| CR-Plug (RTI Biologics, Inc.) | 68 | 1 |
| OsteoAMP-putty (Advanced Biologics LLC) | 68 | 1 |
| OsteoAMP-sponge (Advanced Biologics LLC) | 68 | 1 |
| Viscosupplementation | 68 | 1 |
| Durolane (Q-Med AB) | 68 | 1 |
| Monovisc (Anika Therapeutics, Inc.) | 68 | 1 |
| CINGAL (Anika Therapeutics, Inc.) | 68 | 1 |
| DBM | 69 | 1 |
| Origen DBM (Orthofix International N.V.) | 69 | 1 |
| Super-inductive DBM (RTI Biologics, Inc.) | 69 | 1 |
| List of Pipeline Products | 69 | 1 |
| Pipeline Product Summary | 69 | 4 |
| Global Orthobiologics Market: Consolidation Landscape | 73 | 5 |
| Key Deals | 75 | 1 |
| Medtronic to Acquire Osteotech | 75 | 1 |
| Strategic Rationale: | 75 | 1 |
| Landec Acquires Lifecore Biomedical | 75 | 1 |
| Strategic Rationale: | 76 | 1 |
| Baxter International Completes Acquisition Of ApaTech | 76 | 1 |
| Strategic Rationale: | 76 | 1 |
| TiGenix Completes Acquisition Of OrthoMimetics | 76 | 1 |
| Strategic rationale: | 76 | 1 |
| NuVasive Invests In Progentix Orthobiology | 76 | 1 |
| Strategic Rationale: | 77 | 1 |
| Kinetic Concepts Acquires LifeCell | 77 | 1 |
| Strategic Rationale: | 77 | 1 |
| Pioneer Surgical Acquires Angstrom Medica | 77 | 1 |
| Strategic Rationale: | 77 | 1 |
| Pioneer Surgical Technology Acquires Encelle | 77 | 1 |
| Strategic Rationale: | 77 | 1 |
| Orthofix Acquires Blackstone Medical | 77 | 1 |
| Strategic rationale: | 77 | 1 |
| Appendix | 78 | 4 |
| Definitions | 78 | 1 |
| Orthobiologics | 78 | 1 |
| Bone Allografts | 78 | 1 |
| Bone Graft Substitute | 78 | 1 |
| Bone Growth Stimulators | 78 | 1 |
| DBM | 78 | 1 |
| Viscosupplementation | 78 | 1 |
| Acronyms | 78 | 1 |
| Sources | 79 | 1 |
| Research Methodology | 79 | 2 |
| Secondary Research | 79 | 1 |
| Primary Research | 79 | 1 |
| Models | 80 | 1 |
| Forecasts | 80 | 1 |
| Expert Panels | 80 | 1 |
| Contact Us | 81 | 1 |
| Disclaimer | 81 | 1 |